Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 3,200,000 | 3,350,000 | +150,000 | $189.34M | $167.37M | 10.46% | -$21.98M |
| Vera Therapeutics, Inc.CL A(VERA) | 2,475,000 | 2,475,000 | 0 | $89.55M | $109.39M | 6.84% | +$19.85M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,754,266 | 2,700,000 | -54,266 | $107.39M | $106.30M | 6.64% | -$1.09M |
| Vaxcyte, Inc.(PCVX) | 1,305,000 | 920,000 | -385,000 | $98.54M | $105.13M | 6.57% | +$6.59M |
| Enliven Therapeutics Inc | 3,973,245 | 4,100,000 | +126,755 | $92.85M | $104.71M | 6.54% | +$11.86M |
| Nuvalent Inc | 1,487,756 | 940,000 | -547,756 | $112.86M | $96.16M | 6.01% | -$16.70M |
| Cogent Biosciences, Inc.(COGT) | 9,738,000 | 7,539,930 | -2,198,070 | $82.09M | $81.43M | 5.09% | -$660.1K |
| Alkermes plcSHS(ALKS) | 1,375,000 | 2,900,000 | +1,525,000 | $33.14M | $81.17M | 5.07% | +$48.03M |
| Soleno Therapeutics Inc | 1,425,000 | 1,260,000 | -165,000 | $58.14M | $63.62M | 3.98% | +$5.48M |
| Spyre Therapeutics, Inc.(SYRE) | 1,988,084 | 1,988,084 | 0 | $46.74M | $58.47M | 3.65% | +$11.73M |
| Viridian Therapeutics, Inc.(VRDN) | 2,528,032 | 2,550,124 | +22,092 | $32.89M | $58.02M | 3.63% | +$25.13M |
| Celldex Therapeutics, Inc.(CLDX) | 1,425,000 | 1,618,937 | +193,937 | $52.74M | $55.03M | 3.44% | +$2.29M |
| Mind Medicine Mindmed Inc | 7,145,888 | 8,000,000 | +854,112 | $51.52M | $45.52M | 2.84% | -$6.00M |
| Perspective Therapeutics, Inc.(CATX) | 4,657,345 | 3,350,000 | -1,307,345 | $46.43M | $44.72M | 2.79% | -$1.71M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 1,650,000 | +1,650,000 | $0 | $37.08M | 2.32% | +$37.08M |
| Pharvaris N V COM | 1,810,175 | 1,911,433 | +101,258 | $34.03M | $35.40M | 2.21% | +$1.37M |
| Kura Oncology, Inc.(KURA) | 1,593,350 | 1,800,000 | +206,650 | $32.81M | $35.17M | 2.20% | +$2.36M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 1,225,000 | 650,000 | -575,000 | $50.30M | $34.05M | 2.13% | -$16.25M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 1,369,714 | +1,369,714 | $0 | $33.57M | 2.10% | +$33.57M |
| Arvinas, Inc.(ARVN) | 1,884,361 | 1,200,000 | -684,361 | $50.16M | $29.56M | 1.85% | -$20.61M |
| Celcuity Inc.(CELC) | 1,464,105 | 1,522,332 | +58,227 | $23.98M | $22.70M | 1.42% | -$1.28M |
| Centessa Pharmaceuticals PlcADS | 0 | 1,350,000 | +1,350,000 | $0 | $21.59M | 1.35% | +$21.59M |
| Nkarta, Inc.(NKTX) | 4,151,034 | 4,662,073 | +511,039 | $24.53M | $21.07M | 1.32% | -$3.46M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,000,000 | 2,000,000 | 0 | $14.14M | $20.50M | 1.28% | +$6.36M |
| C4 Therapeutics, Inc.(CCCC) | 3,410,384 | 3,410,384 | 0 | $15.76M | $19.44M | 1.21% | +$3.68M |
| Third Harmonic Bio Inc | 1,545,426 | 1,360,569 | -184,857 | $20.09M | $18.44M | 1.15% | -$1.65M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 825,000 | 885,000 | +60,000 | $16.94M | $17.04M | 1.06% | +$99.0K |
| Apogee Therapeutics Inc | 290,000 | 290,000 | 0 | $11.41M | $17.03M | 1.06% | +$5.62M |
| ABIVAX Société AnonymeADS(ABVX) | 1,284,110 | 1,284,110 | 0 | $16.98M | $14.79M | 0.92% | -$2.18M |
| Instil Bio, Inc.(TIL) | 0 | 150,929 | +150,929 | $0 | $10.16M | 0.63% | +$10.16M |
| Neurogene Inc.(NGNE) | 200,000 | 200,000 | 0 | $7.28M | $8.39M | 0.52% | +$1.11M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.54M | $7.51M | 0.47% | -$37.5K |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.11M | $5.22M | 0.33% | +$115.0K |
| Cabaletta Bio, Inc.(CABA) | 1,100,000 | 1,100,000 | 0 | $8.23M | $5.19M | 0.32% | -$3.04M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $5.48M | $4.74M | 0.30% | -$740.3K |
| Avalo Therapeutics, Inc.(AVTX) | 40,000 | 483,000 | +443,000 | $498.8K | $4.59M | 0.29% | +$4.09M |
| Arca Biopharma Inc | 414,325 | 0 | -414,325 | $1.59M | $0 | — | -$1.59M |
| Autolus Therapeutics plcADS(AUTL) | 1,178,723 | 0 | -1,178,723 | $4.10M | $0 | — | -$4.10M |
| Immunovant, Inc.(IMVT) | 750,990 | 0 | -750,990 | $19.83M | $0 | — | -$19.83M |